Updates are available Correction dated 2025-05-19
Click to view Correction: https://doi.org/10.1007/s00392-025-02678-5
-
Authors
Krefting, Johannes
Graesser, Christian
Novacek, Sophie
Voll, Felix
Moggio, Aldo
Krueger, Nils
Friess, Christian
Schwab, Marius
Offenborn, Frank
Trenkwalder, Teresa
Kufner, Sebastian
Xhepa, Erion
Joner, Michael
Cassese, Salvatore
Schunkert, Heribert
Ndrepepa, Gjin
Kastrati, Adnan
von Scheidt, Moritz
Kessler, Thorsten
Sager, Hendrik B. https://orcid.org/0000-0002-0197-6553
-
Funding
Funding for this research was provided by:
HORIZON EUROPE European Research Council (STRATO 759272)
Deutsche Forschungsgemeinschaft (515567441)
Deutsche Forschungsgemeinschaft (470462396)
Technische Universität München
- License Information
-
More Information
Article History
Received: 28 December 2024
Accepted: 24 February 2025
First Online: 20 March 2025
Change Date: 14 May 2025
Change Type: Update
Change Details: The original online version of this article was revised: Captions in Tab. 2 for male and female were mixed-up.
Change Date: 19 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00392-025-02678-5
Declarations
:
: H.B.S. has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (STRATO, grant agreement No. 759272), the “Else-Kröner-Fresenius-Stiftung” (2020_EKSE.07) and the “Deutsche Forschungsgemeinschaft (DFG)” (515567441, 470462396, CRC 1123 (B11)).” T.K.’s work is funded by the European Union (ERC, MATRICARD, 101077205; to T.K.). Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. T.K.’s work is also funded by the Corona Foundation as part of the Junior Research Group Translational Cardiovascular Genomics (S199/10070/2017) and the German Research Foundation (DFG) as part of the collaborative research center SFB 1123 (B2, to T.K. and H.S), the research project KE 2116/4-1), and the Heisenberg Program (KE 2116/5-1). M.v.S. has been supported by an excellence grant of the German Center for Cardiovascular Research (DZHK-81X3600506), and is also funded by the Corona Foundation with as part of the Junior Research Group Somatic Mutations (S199/10085/2021). C.G. has been supported by an excellence grant of the German Center for Cardiovascular Research (FKZ-81X3600511). H.B.S. received lecture fees and travel support from Novo Nordisk Pharma GmbH, AstraZeneca GmbH, Translumina and Abbott Medical GmbH. H.S., A.K. and T.K. are named inventors on a patent application for prevention of restenosis after angioplasty and stent implantation outside the submitted work. T.K. received lecture fees from Translumina, Bristol-Myers Squibb, Abbott, and Astra-Zeneca which are unrelated to this work. S.K. reports speaker and consulting fees from AstraZeneca, Bristol Myers Squibb, and Bentley and speaker fees from Abbott, Boehringer-Ingelheim and Translumina and a research grant from Bentley, not related the current work. Financial support for the establishment of the Observable Database was obtained through the DigiMed Bayern initiative ( ), which is underwritten by the Bavarian State Ministry of Health and Care. It is important to note that the sponsor of the research was not involved in the conception of the study, the gathering or analysis of data, the interpretation of the findings, or the composition of the research paper. This assures the autonomy of the scientific process and the integrity of the study's results.
